特許出願人の記録

APPLICANTS

元の名称記録: Beijing Yingu Medicine Sci Techno Co., Ltd.

原資料の出願人名と、取り込んだ特許の元の名称欄を閲覧します。

名称による検索結果であり、法的主体の同一性を確認したものではありません。同名の個人・組織や旧名称、別名を自動統合しません。

元の名称欄全体に一致する記録です。複数の出願人や別の役割の当事者を含む場合があります。名称の境界や法的主体は未確認であり、句読点を分割しません。

索引済み特許 1 件

№ US20260000654A1発明
審査中

USE OF BENCYCLOQUIDIUM BROMIDE, ISOMER THEREOF AND DERIVATIVE THEREOF IN PREPARATION OF OPHTHALMIC FORMULATION

USE OF BENCYCLOQUIDIUM BROMIDE, ISOMER THEREOF AND DERIVATIVE THEREOF IN PREPARATION OF OPHTHALMIC FORMULATION

The present invention relates to the technical field of medicine, and in particular to a use of bencycloquidium bromide, an isomer thereof and a derivative thereof in the preparation of a drug for preventing or treating an ophthalmic disease. Moreover, the present invention provides an ophthalmic formulation using the bencycloquidium bromide, the isomer thereof and the derivative thereof as active ingredients. According to the present invention, by using the bencycloquidium bromide, the isomer thereof and the derivative thereof in eyes, it is discovered that the bencycloquidium bromide, the isomer thereof and the derivative thereof have an obvious inhibitory effect on changes in ocular axial length and diopter in the progression process of a myopic refractive error, and then it is discovered that the ophthalmic formulation using the bencycloquidium bromide, the isomer thereof and the derivative thereof as active ingredients has significant advantages in the prevention and treatment of ophthalmic diseases, especially in preventing myopia and slowing down the progression of myopia, etc.

❖Beijing Yingu Medicine Sci Techno Co., Ltd.Wenzhan YU; Yuanyuan PAN; Yanyan LI; Fengquan YUAN; Zihan LIU; Qingyuan NI; Ya ZHANG§ 5/13 請求項A61K 31/439, A61K 9/, A61K 9/8 +810